Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs IV Ganciclovir Maintenance for CMV Retinitis in AIDS
NCT00002247Phase 3Completed
- Sponsor
- Roche
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of ganciclovir in cytomegalovirus retinitis, sponsored by Roche. Status: completed.
02
Drugs
ganciclovir
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00002247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002247.